ahlam1399
09-14-2016, 01:00 PM
BRIEF-Exelixis says European commission approves Cabometyx
* European Commission approves Cabometyx tablets for thetreatment of advanced renal cell carci**ma followingVEGF-targeted therapyhttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=zGGuXJk2N54:fNP-dCMxX5M:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=zGGuXJk2N54:fNP-dCMxX5M:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=zGGuXJk2N54:fNP-dCMxX5M:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=zGGuXJk2N54:fNP-dCMxX5M:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=zGGuXJk2N54:fNP-dCMxX5M:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/zGGuXJk2N54
* European Commission approves Cabometyx tablets for thetreatment of advanced renal cell carci**ma followingVEGF-targeted therapyhttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=zGGuXJk2N54:fNP-dCMxX5M:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=zGGuXJk2N54:fNP-dCMxX5M:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=zGGuXJk2N54:fNP-dCMxX5M:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=zGGuXJk2N54:fNP-dCMxX5M:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=zGGuXJk2N54:fNP-dCMxX5M:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/zGGuXJk2N54